Ian James Martins
Chief-Editor
Edith Cowan University,Australia
Australia
Biography
Dr. Ian Martins has been invited to join the Editors of various international journals and has been a reviewer for various journals (approx. 40). He was appointed as the Chief Editor for International Journal of Diabetes Research (2014-2017). He is a BIT Member (BIT Congress. Inc) with an H-index of 43, (ResearchGate STATs (23), Mendeley STATS (20). The total citations over the past 27 years of scientific research has accumulated to 2977. ResearchGate’s analysis available on google, Tweet, Facebook, Lindekin under Ian James Martins’ name places Dr Martins’ publication stats RG score higher than 96% of the international researchers and is now a SCIENTIST (ResearchGate). He is now a Scientist for The Science Advisory Board (USA). He has reached the top 3% of Academia.edu. researchers and is a connecting researcher with ORCID. Prevention of over eating by food restriction improves liver lipid metabolism and nature of fat consumed is important to improving health. Contribution to biology is the peripheral sink abeta hypothesis and its relevance to organ suicide, diabetes and Alzheimer’s disease. Dr Martins has received certificates of recognition at various international conferences, world congress and conventions in relation to anti-aging, health and disease. Keynote addresses at Innovate Pharma 2017, Innovate Neurology 2017, World Diabetes and Endocrinology Summit-2017 and Pharmacology and Ethnopharmacology 2016 has been completed with relevance to the current global epidemic on chronic diseases. Invited 1st Plenary Speaker at the Annual Global Health Conference 2016 with relevance to “Nutritional diets accelerate amyloid beta metabolism and prevent the induction of chronic diseases and Alzheimer’s disease. Photon ebooks†(Dr Ian Martins was conferred with the RICHARD KUHN RESEARCH AWARD-2015 ENDOCRINOLOGY AND METABOLISM).
Research Interest
His current research into links between diet, diabetes and neurodegenerative diseases builds upon his past experiences and generates outputs that will have relevant and significant impact to the community. The incidence of diabetes has been predicted to increase to 21% by 2050. In various continents the rise in the global diabetes epidemic has been associated with diseases of various organ diseases related to obesity, diabetes and neurodegenerative diseases (Parkinson’s disease and Alzheimer’s disease). Novel and critical elements of scholarly peer review provides information that the heat shock gene Sirtuin 1 is repressed with relevance to diabetes, neurological diseases and Alzheimer's disease. Major unsolved challenges to advances in biology may now provide evidence to reverse Sirtuin 1 dysfunction that is connected to primarly to heat shock protein metabolism and secondly to toxic amyloid beta metabolism with mitochondrial apoptosis in liver and brain cells. In the developing world increased levels of bacterial lipopolysaccharides repress the anti-aging gene Sirtuin 1 with the development of diabetes, neurodegenerative diseases and Alzheimer’s disease. Unhealthy diets accelerate Type 3 diabetes with the induction of NAFLD in Global Populations.